Vaccine News and Research

Latest Vaccine News and Research

Messenger RNA COVID-19 vaccines induce high levels of short-lived antibodies compared to natural infection

Researchers extensively investigated the dynamics of antibodies induced by natural SARS-CoV-2 infection and vaccination in Qatar's diverse population

12 May 2022

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

In a recent study posted to the medRxiv* preprint server, researchers estimated the efficacy of two-dose and three-dose regimens of two messenger ribonucleic acid (mRNA) vaccines: Moderna’s mRNA-1273 and Pfizer-BioNTech’s BNT162b2 against coronavirus disease 2019 (COVID-19) caused due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.

12 May 2022

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

In a recent study published in the journal Vaccines, researchers revealed how severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron evades neutralizing antibodies (nAbs).

12 May 2022

The promise of RNA medicine is targeted and personalized

The development of messenger RNA (mRNA) vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has only increased the impetus in this field.

11 May 2022

UMSOM researchers participate in Big Ten health registry to learn about cardiac issues in athletes recovering from COVID-19

Researchers at the University of Maryland School of Medicine (UMSOM) have been collaborating on an extensive heart registry that includes student-athletes in the Big Ten athletic conference, to learn more about cardiac issues in those who have recovered from a COVID-19 infection.

11 May 2022

Study shows efficacy of COVID-19 vaccine in people receiving cancer treatment

People undergoing active cancer treatment, including stem cell transplant, should receive the COVID-19 vaccine, according to a study published in JAMA Oncology.

11 May 2022

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

Researchers reviewed messenger ribonucleic acid (mRNA) technology and highlighted its clinical applications.

11 May 2022

Effectiveness of COVID-19 monoclonal antibodies against SARS-CoV-2 Omicron variant

Researchers depicted the efficacy of the SARS-CoV-2 monoclonal antibodies (mAbs) against the SARS-CoV-2 Omicron variant.

11 May 2022

Vaccine features that could induce durable humoral immune responses against SARS-CoV-2

A new study explored key vaccine features which could help induce and preserve humoral immunity against SARS-CoV-2 infection.

11 May 2022

Susceptibility of four SARS-CoV-2 Omicron sub-lineages to vaccines and monoclonal antibodies

Researchers demonstrated that four SARS-CoV-2 Omicron sub-lineages, BA.1, BA.1.1, BA.2, and BA.3, are resistant to current COVID-19 vaccines and antibody therapeutics to varying extents.

11 May 2022

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

Three historically neglected diseases - the 'Big Three', namely tuberculosis, malaria and HIV/AIDS- could be set to benefit from the phenomenal strides that have occurred in vaccine technology in the 2020s.

11 May 2022

Researchers warn against national strategies for a "new normal" of life with COVID-19

Researchers are warning U.S. leaders and health officials against national strategies for a "new normal" of life with COVID-19.

10 May 2022

Narcissism affects an individual's willingness to comply with COVID-19 mitigations

Throughout the COVID-19 pandemic, experts have encouraged mitigation strategies like masking and vaccination to help reduce the spread of the virus.

10 May 2022

Exploring simultaneous and sequential COVID-19 vaccine candidate

Researchers developed novel lipid nanoparticle (LNP)-based messenger ribonucleic acid vaccine formulations against three pathogenic coronaviruses.

10 May 2022

Evasion of COVID-19 vaccine-medicated mucosal immunity by SARS-CoV-2 Omicron

Researchers depicted the evasion of the SARS-CoV-2 Omicron variant to mucosal immunity in SARS-CoV-2 vaccine recipients.

10 May 2022

Heightened antibody responses in COVID-19 booster vaccinated individuals following SARS-CoV-2 Omicron

Investigators illustrated that a SARS-CoV-2 Omicron infection post-booster vaccination imparts robust, long-lasting immunity against future re-infections.

10 May 2022

SARS-CoV-2 Omicron infection boosts Delta immunity in those who have been vaccinated

A new study published in the journal Nature aimed to determine the extent to which Omicron infection elicits protection against other SARS-CoV-2 variants in both vaccinated and unvaccinated individuals.

10 May 2022

CDC/FDA reports on VAERS - no association between vaccines and increased mortality

A U.S. population-wide study published in medRxiv* preprint server provides information and context about deaths reported to VAERS following COVID-19 vaccination.

10 May 2022

mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

A study recently published in the journal Cell Host & Microbe has described that all three sublineages of the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit similar host cell entry efficiency and are neutralized equally by antibodies generated in response to coronavirus disease 2019 (COVID-19) booster vaccination

10 May 2022

More evidence that pediatric COVID vaccination prevents MIS-C

Researchers designed a nationwide pediatric COVID-19 research project based on real-time data since the early phase of the pandemic.

9 May 2022

Vaccine News and Research

Latest Vaccine News and Research

Messenger RNA COVID-19 vaccines induce high levels of short-lived antibodies compared to natural infection

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

The promise of RNA medicine is targeted and personalized

UMSOM researchers participate in Big Ten health registry to learn about cardiac issues in athletes recovering from COVID-19

Study shows efficacy of COVID-19 vaccine in people receiving cancer treatment

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

Effectiveness of COVID-19 monoclonal antibodies against SARS-CoV-2 Omicron variant

Vaccine features that could induce durable humoral immune responses against SARS-CoV-2

Susceptibility of four SARS-CoV-2 Omicron sub-lineages to vaccines and monoclonal antibodies

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

Researchers warn against national strategies for a "new normal" of life with COVID-19

Narcissism affects an individual's willingness to comply with COVID-19 mitigations

Exploring simultaneous and sequential COVID-19 vaccine candidate

Evasion of COVID-19 vaccine-medicated mucosal immunity by SARS-CoV-2 Omicron

Heightened antibody responses in COVID-19 booster vaccinated individuals following SARS-CoV-2 Omicron

SARS-CoV-2 Omicron infection boosts Delta immunity in those who have been vaccinated

CDC/FDA reports on VAERS - no association between vaccines and increased mortality

mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

More evidence that pediatric COVID vaccination prevents MIS-C

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in